|
⚲
|
| Keyboard |
| Tavakkol Roxanne
✚
|
|
|---|---|
| CIK # | 0001502054 |
| EDGAR Form | CIK | 2011 - 2026 |
|---|---|---|
| 4 | [0001502054] |
| Form 3/4/5 Subject | 2011 - 2026 |
|---|---|
| Unigene Laboratories Inc | |
| Tavakkol Roxanne |
| Insider Transaction (Form 3/4/5) | Date | Action | Shares | Price | Value ($) |
|---|---|---|---|---|---|
|
Unigene Laboratories Inc UGNE
Stock Option · derivative
|
2012-09-27 | Grant | 120,782 | $0.00 | |
|
Unigene Laboratories Inc UGNE
Stock Option · derivative
|
2012-09-27 | Grant | 545,000 | $0.00 | |
|
Unigene Laboratories Inc UGNE
Stock Options · derivative
|
2012-03-15 | Grant | 50,000 | $0.00 | |
|
Unigene Laboratories Inc UGNE
Stock Options · derivative
|
2012-03-15 | Grant | 50,000 | $0.00 | |
|
Unigene Laboratories Inc UGNE
Stock Options · derivative
|
2012-03-15 | Grant | 50,000 | $0.00 | |
|
Unigene Laboratories Inc UGNE
Stock Option · derivative
|
2012-01-13 | Grant | 27,000 | $0.00 | |
|
Unigene Laboratories Inc UGNE
Stock Option · derivative
|
2012-01-13 | Grant | 39,006 | $0.00 |